Novo Nordisk President and CEO Mike Doustdar Talks Wegovy Pill

from Bloomberg Talks · host Bloomberg

Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Dec 23, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Novo Nordisk President and CEO Mike Doustdar Talks Wegovy Pill

0:00 8:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Bloomberg Talks?

This episode is 8 minutes long.

When was this Bloomberg Talks episode published?

This episode was published on December 23, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Bloomberg Talks episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!